Most recently acquired 8,649 shares in Jun 2024. Currently holds stock worth $899.08K.
Compensation History
Annual executive compensation data for Kimberly J. Popovits, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$0.00
Salary
$0.00
Bonus
$0.00
Other
$0.00
Salary
$0.00Board Justification
The compensation philosophy emphasizes pay-for-performance and aligns executive compensation with company performance and market benchmarks.
Bonus
$0.00Board Justification
No bonus was awarded to Kimberly J. Popovits in 2023.
Other Compensation
$0.00Board Justification
No other compensation was reported for Kimberly J. Popovits in 2023.
Restricted Stock
Board Justification
No stock awards vested in 2023 for Kimberly J. Popovits.
Performance Metrics
Performance metrics for Kimberly J. Popovits' compensation were based on company performance, but specific metrics were not disclosed.
Kimberly J. Popovits
Ex-CEO of Talis Biomedical
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
CEO of Talis Biomedical for
0 years 3 months (Aug 2021 - Dec 2021)
Previous Experience
Former Chair of the Board of Directors, President and Chief Executive Officer of Genomic Health.
Other Talis Biomedical CEOs
Holdings
Track Kimberly J. Popovits's stock holdings and portfolio value over time.
Insider Trading
Kimberly J. Popovits's recent stock transactions, purchases, and sales filed with the SEC.
8,649 shares
TXG
Jun 11, 2024
Received
1,865 shares
TXG
Jun 14, 2023
Received
2,120 shares
TXG
Jun 15, 2022
Received
625 shares
TXG
Jun 11, 2021
Received
Rivals
Compare Kimberly J. Popovits with competitor CEOs and industry peers.